Skip to search formSkip to main contentSkip to account menu

serogroup C meningococcal conjugate vaccine

Known as: meningococcal type C conjugate vaccine, meningococcal C conjugate vaccine, meningococcal C conjugate 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Meningococcal vaccine

Narrower (1)

Mnc-CRM197

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
A Comparison of Pyrogen Detection Tests in the Quality Control of Meningococcal Conjugate Vaccines: The Applicability of the Monocyte Activation Test
The meningococcal C conjugate vaccine (MenCC) is an interesting model with which to test the efficacy of the Monocyte Activation… 
2016
2016
Reduction in Neisseria meningitidis infection in Italy after Meningococcal C conjugate vaccine introduction: A time trend analysis of 1994–2012 series
The incidence of invasive meningococcal disease (IMD) in Italy is among the lowest in Europe. Meningococcal C conjugate vaccine… 
2015
2015
Estimation of the Impact of Meningococcal Serogroup C Universal Vaccination in Italy and Suggestions for the Multicomponent Serogroup B Vaccine Introduction
In Italy, the meningococcal C conjugate vaccine (MenC) has been offered in most regions since 2009-2010. The incidence of… 
2014
2014
Efetividade da vacina meningocócica C conjugada e caracterização da Neisseria meningitidis em Salvador, Bahia
Introduction: Meningococcal disease (MD) is caused by bacterium Neisseria meningitidis and is a major public health problem… 
2012
2012
Immunogenicity of a Single Dose of Meningococcal Group C Conjugate Vaccine Given at 3 Months of Age to Healthy Infants in the United Kingdom
Background: From 1999, in the United Kingdom, meningococcal C conjugate (MCC) vaccines from 3 manufacturers were introduced to… 
Review
2012
Review
2012
A critical appraisal of the recommendations for the use of meningococcal conjugate vaccines
Objectives: To assess the epidemiology of meningococcal disease (MD) in Brazil and the impact that recent evidence and lessons… 
Review
2012
Review
2012
Editorial Commentary: The Endgame for Serogroup A Meningococcal Disease in Africa?
(See the Major Article by Kristiansen et al on pages 354–63.) Since 1905 the “meningitis belt” of sub-Saharan Africa, has… 
2012
2012
Vaccination programmes against invasive disease in Italy, with particular regard to Valle d'Aosta.
This letter is based on my experience of technical meetings aimed at preparing documents on vaccination programmes for the… 
2010
2010
Vaccinating premature infants in a Special Care Baby Unit in the UK: results of a prospective, non-inferiority based, pragmatic case series study
Premature infants are at greater risk of infections in part because of impaired functioning of external barriers, innate and… 
2006
2006
Reactogenicity of Meningococcal C Conjugate Vaccines When Administered at the Same Time as, or a Month Prior to or After, Tetanus and Diphtheria Booster Vaccinations
Introduction: This single blind study was conducted to address safety concerns regarding co-administration of diphtheria/ tetanus… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)